Vektor vMap™ Clinical Validation Study

CompletedOBSERVATIONAL
Enrollment

225

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

April 6, 2021

Study Completion Date

April 6, 2021

Conditions
Cardiac ArrhythmiaAtrial FibrillationVentricular ArrythmiaPremature Ventricular Complexes MultipleVentricular TachycardiaVentricular FibrillationPremature Atrial ComplexAtrioventricular Reentrant Tachycardia
Interventions
DEVICE

Cardiac ablation procedure

Retrospective data will be collected from cases where successful ablation was completed.

Trial Locations (4)

29425

Medical University of South Carolina, Charleston

92093

University of California San Diego Health, La Jolla

92161

VA San Diego Healthcare System, San Diego

94107

Sutter Health, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Experien Group

UNKNOWN

lead

Vektor Medical

INDUSTRY

NCT04559061 - Vektor vMap™ Clinical Validation Study | Biotech Hunter | Biotech Hunter